- Home
- LODE vs PALI Comparison
LODE vs PALI Comparison
Compare LODE & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LODE | PALI |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.1M | 240.2M |
| IPO Year | 2004 | 2019 |
Fundamental Metrics
Financial Performance| Metric | LODE | PALI |
|---|---|---|
| Price | $3.27 | $1.91 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $4.00 | ★ $12.00 |
| AVG Volume (30 Days) | 1.1M | ★ 3.9M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 63.55 | ★ 97.06 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,553,796.00 | $260,000.00 |
| Revenue This Year | $1,429.67 | N/A |
| Revenue Next Year | $270.86 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $1.85 | $0.55 |
| 52 Week High | $4.80 | $2.64 |
Technical Indicators
Market Signals| Indicator | LODE | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 54.15 | 51.31 |
| Support Level | $3.11 | $1.58 |
| Resistance Level | $3.43 | $2.05 |
| Average True Range (ATR) | 0.24 | 0.17 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 68.50 | 61.76 |
Price Performance
Historical ComparisonAbout LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.